Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance

Yuzhi Dong, Chen Xu, Xilin Zhao, John Domagala, Karl Drlica

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Fluoroquinolones trap gyrase on DNA as bacteriostatic complexes from which lethal DNA breaks are released. Substituents at the C-8 position increase activities of N-1-cyclopropyl fluoroquinolones against several bacterial species. In the present study, a C-8-methoxyl group improved bacteriostatic action against gyrA (gyrase-resistant) strains of Mycobacterium tuberculosis and M. bovis BCG. It also enhanced lethal action against gyrase mutants of M. bovis BCG. When cultures of M. smegmatis, M. bovis BCG, and M. tuberculosis were challenged with a C-8-methoxyl fluoroquinolone, no resistant mutant was recovered under conditions in which more than 1,000 mutants were obtained with a C-8-H control. A C-8-bromo substituent also increased bacteriostatic and lethal activities against a gyrA mutant of M. bovis BCG. When lethal activity was normalized to bacteriostatic activity, the C-8-methoxyl compound was more bactericidal than its C-8-H control, while the C-8-bromo fluoroquinolone was not. The C-8- methoxyl compound was also found to be more effective than the C-8-bromo fluoroquinolone at reducing selection of resistant mutants when each was compared to a C-8-H control over a broad concentration range. These data indicate that a C-8-methoxyl substituent, which facilitates attack of first- step gyrase mutants, may help make fluoroquinolones effective antituberculosis agents.

Original languageEnglish (US)
Pages (from-to)2978-2984
Number of pages7
JournalAntimicrobial agents and chemotherapy
Volume42
Issue number11
StatePublished - Nov 1 1998
Externally publishedYes

Fingerprint

Fluoroquinolones
Mycobacterium
Mycobacterium bovis
Growth
Mycobacterium tuberculosis
Smegma
DNA Gyrase
DNA Breaks

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{ed06e4f785d44b70a53af251783ffe28,
title = "Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance",
abstract = "Fluoroquinolones trap gyrase on DNA as bacteriostatic complexes from which lethal DNA breaks are released. Substituents at the C-8 position increase activities of N-1-cyclopropyl fluoroquinolones against several bacterial species. In the present study, a C-8-methoxyl group improved bacteriostatic action against gyrA (gyrase-resistant) strains of Mycobacterium tuberculosis and M. bovis BCG. It also enhanced lethal action against gyrase mutants of M. bovis BCG. When cultures of M. smegmatis, M. bovis BCG, and M. tuberculosis were challenged with a C-8-methoxyl fluoroquinolone, no resistant mutant was recovered under conditions in which more than 1,000 mutants were obtained with a C-8-H control. A C-8-bromo substituent also increased bacteriostatic and lethal activities against a gyrA mutant of M. bovis BCG. When lethal activity was normalized to bacteriostatic activity, the C-8-methoxyl compound was more bactericidal than its C-8-H control, while the C-8-bromo fluoroquinolone was not. The C-8- methoxyl compound was also found to be more effective than the C-8-bromo fluoroquinolone at reducing selection of resistant mutants when each was compared to a C-8-H control over a broad concentration range. These data indicate that a C-8-methoxyl substituent, which facilitates attack of first- step gyrase mutants, may help make fluoroquinolones effective antituberculosis agents.",
author = "Yuzhi Dong and Chen Xu and Xilin Zhao and John Domagala and Karl Drlica",
year = "1998",
month = "11",
day = "1",
language = "English (US)",
volume = "42",
pages = "2978--2984",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "11",

}

Fluoroquinolone action against mycobacteria : Effects of C-8 substituents on growth, survival, and resistance. / Dong, Yuzhi; Xu, Chen; Zhao, Xilin; Domagala, John; Drlica, Karl.

In: Antimicrobial agents and chemotherapy, Vol. 42, No. 11, 01.11.1998, p. 2978-2984.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fluoroquinolone action against mycobacteria

T2 - Effects of C-8 substituents on growth, survival, and resistance

AU - Dong, Yuzhi

AU - Xu, Chen

AU - Zhao, Xilin

AU - Domagala, John

AU - Drlica, Karl

PY - 1998/11/1

Y1 - 1998/11/1

N2 - Fluoroquinolones trap gyrase on DNA as bacteriostatic complexes from which lethal DNA breaks are released. Substituents at the C-8 position increase activities of N-1-cyclopropyl fluoroquinolones against several bacterial species. In the present study, a C-8-methoxyl group improved bacteriostatic action against gyrA (gyrase-resistant) strains of Mycobacterium tuberculosis and M. bovis BCG. It also enhanced lethal action against gyrase mutants of M. bovis BCG. When cultures of M. smegmatis, M. bovis BCG, and M. tuberculosis were challenged with a C-8-methoxyl fluoroquinolone, no resistant mutant was recovered under conditions in which more than 1,000 mutants were obtained with a C-8-H control. A C-8-bromo substituent also increased bacteriostatic and lethal activities against a gyrA mutant of M. bovis BCG. When lethal activity was normalized to bacteriostatic activity, the C-8-methoxyl compound was more bactericidal than its C-8-H control, while the C-8-bromo fluoroquinolone was not. The C-8- methoxyl compound was also found to be more effective than the C-8-bromo fluoroquinolone at reducing selection of resistant mutants when each was compared to a C-8-H control over a broad concentration range. These data indicate that a C-8-methoxyl substituent, which facilitates attack of first- step gyrase mutants, may help make fluoroquinolones effective antituberculosis agents.

AB - Fluoroquinolones trap gyrase on DNA as bacteriostatic complexes from which lethal DNA breaks are released. Substituents at the C-8 position increase activities of N-1-cyclopropyl fluoroquinolones against several bacterial species. In the present study, a C-8-methoxyl group improved bacteriostatic action against gyrA (gyrase-resistant) strains of Mycobacterium tuberculosis and M. bovis BCG. It also enhanced lethal action against gyrase mutants of M. bovis BCG. When cultures of M. smegmatis, M. bovis BCG, and M. tuberculosis were challenged with a C-8-methoxyl fluoroquinolone, no resistant mutant was recovered under conditions in which more than 1,000 mutants were obtained with a C-8-H control. A C-8-bromo substituent also increased bacteriostatic and lethal activities against a gyrA mutant of M. bovis BCG. When lethal activity was normalized to bacteriostatic activity, the C-8-methoxyl compound was more bactericidal than its C-8-H control, while the C-8-bromo fluoroquinolone was not. The C-8- methoxyl compound was also found to be more effective than the C-8-bromo fluoroquinolone at reducing selection of resistant mutants when each was compared to a C-8-H control over a broad concentration range. These data indicate that a C-8-methoxyl substituent, which facilitates attack of first- step gyrase mutants, may help make fluoroquinolones effective antituberculosis agents.

UR - http://www.scopus.com/inward/record.url?scp=0031753298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031753298&partnerID=8YFLogxK

M3 - Article

C2 - 9797236

AN - SCOPUS:0031753298

VL - 42

SP - 2978

EP - 2984

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 11

ER -